It is a drug for the treatment of seizures like epilepsy. “ZYNAPS” (without an e) is owned by Zuneca. (GR 211850, 8 September 2020), the two competing marks involved were “ZYNAPS” and “ZYNAPSE.” They were admitted by both parties to be confusingly similar with each other. In Zuneca Pharmaceutical vs Natrapharm Inc.
Published 23 November 2020, The Daily TribuneĬonsider the brands “ZYNAPS” and “ZYNAPSE.” Are these two related? Do they refer to the same product? These were the questions that hounded a recent decision of the Supreme Court (SC) in Trademark Law which once and for all settled the rule on whose trademark shall prevail between the “first filer” and the “first user.”
